Alpha-7 nicotinic acetylcholine receptor (nAChR) agonist inhibits the development of endometriosis by regulating inflammation

Kaori Yamada-Nomoto, Kaori Yamada‐Nomoto, Yamada-Nomoto K, Yoshino O, Osamu Yoshino, Ikumi Akiyama, Akiyama I, Ushijima A, Akemi Ushijima, Ono Y, Yosuke Ono, Shima T, Tomoko Shima, Nakashima A, Akitoshi Nakashima, Shusaku Hayashi, Makoto Kadowaki, Kadowaki M, Yutaka Osuga, Osuga Y, Shigeru Saito, Saito S
American journal of reproductive immunology (New York, N.Y. : 1989) · 2016 · vol. 76(6) , pp. 491–498 · doi:10.1111/aji.12592 · PMID:27766701 · W2537573614
Lab / animal OA: closed CC0 ⤵ 8 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

Activation of alpha-7 nicotinic acetylcholine receptors suppresses inflammation and endometriotic lesion development in a mouse model by reducing IL-1β expression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: We investigated α-7 nAchR expression in human peritoneal macrophages and examined whether activation of nAchR might be a new therapy for endometriosis. MATERIALS AND METHODS: Human peritoneal fluid mononuclear cells (PFMC) were stimulated with lipopolysaccharide (LPS) in the presence of α-7 nAChR agonists. In a murine endometriosis model, α-7 nAChR modulators were administered. RESULTS: Human PFMC expressed α-7 nAChR at the mRNA and protein levels. Activation of α-7 nAChR with its agonists led to significant (P<.01) suppression of LPS-induced interleukin (IL) -1β expression. In a murine endometriosis model, one week after inoculation of endometrium to the peritoneal cavity, α-7 nAChR agonist significantly suppressed the expression of IL-1β mRNA (P<.01), which was negated when α-7 nAChR antagonist was administered simultaneously. α-7 nAChR agonist significantly suppressed the formation of endometriotic lesions, which was reversed with α-7 nAChR antagonist. CONCLUSION: Activation of nAChR might be a new candidate for treatment of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Aconitine alpha7 Nicotinic Acetylcholine Receptor Bridged Bicyclo Compounds, Heterocyclic Endometriosis Macrophages, Peritoneal Quinuclidines RNA, Messenger Aconitine Aconitine Aconitine Adult Adult alpha7 Nicotinic Acetylcholine Receptor alpha7 Nicotinic Acetylcholine Receptor alpha7 Nicotinic Acetylcholine Receptor alpha7 Nicotinic Acetylcholine Receptor alpha7 Nicotinic Acetylcholine Receptor Animals Animals Ascitic Fluid

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (34)

Cited by (9)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:18:51.237577+00:00
unpaywall
last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0 · commercial use OK